Create a free account

B3 · BRL

MATD3

Hospital Mater Dei SA

R$5.06+0.40% (R$0.02)
Day's range
R$4.96 – R$5.14
Day's volume
R$2.4M
52-week range
R$4.13 – R$6.17

Follow MATD3 in the Fuolio

See how MATD3 weighs in your net worth, what it has paid you and how far it is from your target allocation.

Create a free account

MATD3 in numbers

Market cap
R$1.7B
P/E
11.90
P/B
1.13
Dividend yield (12m)
2.97%
Net debt/EBITDA
1.43

The 12-month dividend yield of MATD3 is 2.97%, above its 5-year average of 2.60%.

MATD3 price history

10/01/202509/30/2026
Compare with

MATD3 risk and return

Monthly closes adjusted for splits and distributions.

Metric12 months36 months60 months
Return+22.70%-23.50%-62.63%
Volatility (annualized)24.94%29.28%36.62%
Largest drawdown-18.79%-55.82%-76.98%
Positive months8/1217/3626/60

How much did investing in MATD3 return?

R$1,000.00 invested on 10/01/2021 would be worth R$373.74 today.

Value today in MATD3
R$373.74
Return over the period
-62.63%
Return per year
-17.88%
In the Ibovespa
R$1,777.43

With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.

MATD3 fundamentals

Valuation

  • P/E
    11.90
  • P/B
    1.13
  • EV/EBITDA
    4.70
  • EV/EBIT
    6.04
  • EV/Revenue
    1.05
  • P/EBIT
    4.21
  • P/S
    0.73
  • P/OCF
    6.75
  • P/FCF
    7.71
  • Earnings yield
    16.54%
  • PEG ratio
    1.29
  • Earnings per share
    R$0.43
  • Book value per share
    R$4.48

Debt

  • Net debt
    R$737.1M
  • Net debt/EBITDA
    1.43
  • Net debt/Equity
    0.49
  • Debt/Equity
    0.91
  • Current ratio
    2.87
  • Quick ratio
    2.73
  • Cash ratio
    1.15

Efficiency

  • Gross margin
    30.34%
  • EBITDA margin
    22.25%
  • Operating margin
    17.30%
  • Net margin
    6.13%
  • Asset turnover
    0.53

Profitability

  • ROE
    9.50%
  • ROA
    3.25%
  • ROIC
    11.93%
  • Payout
    35.41%

Growth

  • Revenue CAGR (5 years)
    —
  • Earnings CAGR (5 years)
    —
  • Revenue growth (year)
    -2.28%
  • Earnings growth (year)
    132.65%
  • Revenue growth (quarter)
    10.26%
  • Earnings growth (quarter)
    9.23%

What is MATD3's fair price?

Two classic value formulas, with today's numbers. The current price is R$5.06.

Graham's fair price
R$6.54
29.30% above the price

√(22.50 × R$0.43 × R$4.48)

Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.

Bazin's ceiling price
R$2.20
56.44% below the price

R$0.13 (4-year average) ÷ 6%

Décio Bazin only bought stocks yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years over 6%.

Graham ignores growth and debt; Bazin assumes past distributions repeat. They are references to compare, not a buy recommendation.

MATD3's indicators by year

Multiples at each year's closing price; margins and returns from that year's statements.

Indicator202520242023202220212020
P/E16.16-3.7126.6826.6335.99—
P/B1.210.851.821.623.10—
EV/EBITDA5.51—7.858.3717.83—
Dividend yield4.28%4.10%0.77%1.25%——
Earnings per shareR$0.33-R$0.98R$0.31R$0.27R$0.38R$0.22
Book value per shareR$4.35R$4.28R$4.59R$4.45R$4.40R$0.78
ROE7.48%-22.92%6.82%6.08%8.61%27.83%
ROIC10.51%-9.81%10.65%8.83%10.64%35.51%
Gross margin29.95%30.13%32.54%35.35%39.51%40.41%
EBITDA margin21.37%-10.19%24.03%24.27%27.64%21.63%
Net margin5.08%-15.20%5.47%5.87%14.15%10.12%
Net debt/EBITDA1.67—1.781.93-0.59-0.18

MATD3's financial statements

Line202520242023202220212020
Net revenueR$2.2BR$2.2BR$2.2BR$1.8BR$1BR$717.9M
Cost of revenue-R$1.5B-R$1.6B-R$1.5B-R$1.1B-R$619.7M-R$427.8M
Gross profitR$651.4MR$670.6MR$711.8MR$623.2MR$404.7MR$290.1M
EBITDAR$464.8M-R$226.8MR$525.6MR$428MR$283.1MR$155.3M
EBITR$353.7M-R$335.8MR$423.6MR$337.9MR$242.3MR$116.8M
Financial result-R$186.6M-R$162.8M-R$214.8M-R$152.1M-R$21.8M-R$14M
Income before taxR$167.1M-R$498.6MR$208.8MR$185.8MR$220.5MR$102.8M
Income tax-R$55.2MR$174.7M-R$67.5M-R$63.1M-R$73.6M-R$30.1M
Net incomeR$110.5M-R$338.4MR$119.7MR$103.5MR$144.9MR$72.6M

Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.

MATD3 against its sector

The same indicators for the company's other shares and the sector's largest stocks.

StockP/EP/BDividend yield (12m)ROEMarket cap
MATD3Hospital Mater Dei S/a11.901.132.97%9.50%R$1.7B
RDOR3REDE DOR SÃO LUIZ S.A.17.794.1410.99%23.26%R$85.8B
SAUD3SAUD337.042.093.05%5.63%R$39B
FLRY3FLEURY S.A.17.712.305.70%13.00%R$12.5B
DASA3DIAGNOSTICOS DA AMERICA S.A.-5.640.740.00%-13.09%R$5B
HAPV3HAPVIDA PARTICIPACOES E INVESTIMENTOS SA-19.310.070.00%-0.36%R$3.4B

Does MATD3 pay dividends?

Dividend yield per year

  • 1.25%2022
  • 0.77%2023
  • 4.10%2024
  • 4.28%2025
  • 0.00%2026
Payment history
TypeLast day to ownPaymentPer share
Dividend12/08/202512/22/2025R$0.15
Dividend05/13/202505/22/2025R$0.07
Dividend04/30/202406/28/2024R$0.07
Dividend04/30/202406/14/2024R$0.07
Dividend04/28/202305/10/2023R$0.06
Dividend04/29/202205/10/2022R$0.09
Splits, reverse splits and bonus shares
EventLast day to ownRatio
Split04/08/20215 for 2

About Hospital Mater Dei S/a

Sector
Saúde
Segment
Serv.Méd.Hospit..Análises e Diagnósticos
Listing segment
Novo Mercado
Tag along
100.00%
Free float
17.16%
Shares issued
333.55M common
Average daily trading
R$1M
Listed since
04/16/2021
CNPJ
16.676.520/0001-59

A Hospital Mater Dei S.A. opera uma rede hospitalar privada com foco em serviços de alta complexidade, incluindo pronto-socorro, internação, centro cirúrgico, UTI, oncologia e diagnóstico. A companhia expandiu sua plataforma por crescimento orgânico e aquisições, buscando presença geográfica ampliada e maior integração entre hospitais, centros médicos e serviços de apoio assistencial. Fundada em 1980 em Belo Horizonte, a empresa evoluiu de hospital único para uma rede multiunidades com atuação em Minas Gerais e outros estados. A geração de receita é vinculada a atendimentos de convênios e particulares, com sensibilidade a mix de procedimentos, ocupação de leitos, custo médico-hospitalar e eficiência operacional. No setor de saúde suplementar, a companhia compete por qualidade clínica, capacidade instalada e gestão de desfechos assistenciais.

Investor website
ShareholdersAs of 12/31/2026, from the Formulário de Referência filed with the CVM.
ShareholderCommonPreferredTotal
JSS Empreendimentos e Administração LTDA.Controlling65.74%0.00%65.74%
HENRIQUE MORAES SALVADOR SILVAControlling3.77%0.00%3.77%
MÁRCIA SALVADOR GÉOControlling2.64%0.00%2.64%
RENATO MORAES SALVADOR SILVAControlling2.48%0.00%2.48%
FELIPE SALVADOR LIGÓRIOControlling1.77%0.00%1.77%
FLAVIA SALVADOR LIGÓRIOControlling1.77%0.00%1.77%
MARIA NORMA SALVADOR LIGÓRIOControlling0.76%0.00%0.76%
GUY SALVADOR GEOControlling0.57%0.00%0.57%
LARA SALVADOR GEOControlling0.57%0.00%0.57%
LIVIA SALVADOR GEOControlling0.57%0.00%0.57%
RAFAEL SABINO SALVADORControlling0.37%0.00%0.37%
RENATA SABINO SALVADOR GRANDEControlling0.37%0.00%0.37%
ANNA DIAS SALVADORControlling0.24%0.00%0.24%
JOSÉ HENRIQUE DIAS SALVADORControlling0.21%0.00%0.21%
JULIA DIAS SALVADORControlling0.20%0.00%0.20%
Outros17.16%0.00%17.16%
Ações Tesouraria0.78%0.00%0.78%

Questions about MATD3

How much is MATD3 today?

MATD3 is at R$5.06 (0.40% on the day), last traded on 10/01/2026.

How much did MATD3 pay in dividends in 2025?

MATD3 paid R$0.23 per share in 2025, a dividend yield of 4.28%.

What are the P/E and P/B of MATD3?

MATD3 trades at a P/E of 11.90 and a P/B of 1.13.

How much did MATD3 return in 12 months?

MATD3 returned 22.70% in 12 months, with annualized volatility of 24.94% and a largest drawdown of -18.79%.

What sector is MATD3 in?

Hospital Mater Dei S/a is in the Saúde sector, Serv.Méd.Hospit..Análises e Diagnósticos segment.